Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Genes & Diseases
|
March 26, 2026
<i>SF3B1</i> <sup>K700E</sup>-driven transcriptional alterations in hematopoietic progenitors underlie blood cancer pathophysiology
Mengzhu Xue, Jianhong An, Erqiang Hu, et al.
Kidney & Blood Pressure Research
|
February 18, 2024
Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury
Shanshan Zou, Jianing Chen, Peihui Zhou, et al.
Journal of Chemical Information and Modeling
|
August 5, 2010
Knowledge-based scoring functions in drug design. 1. Developing a target-specific method for kinase-ligand interactions
Mengzhu Xue, Mingyue Zheng, Bing Xiong, et al.
Scientific Reports
|
June 24, 2014
3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network
Li Li, Duolin Wang, Mengzhu Xue, et al.
BMC Bioinformatics
|
January 27, 2010
BSSF: a fingerprint based ultrafast binding site similarity search and function analysis server
Bing Xiong, Jie Wu, David L Burk, et al.
Molecular Cancer
|
October 23, 2021
Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
Yanli Jin, Ke Ding, Honglin Li, et al.
Nucleic Acids Research
|
March 2, 2016
Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition
Hongyuan Chang, Yuwei Liu, Mengzhu Xue, et al.
Current Pharmaceutical Design
|
May 11, 2012
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives
Mengzhu Xue, Xianwen Cao, Ye Zhong, et al.
Molecular Cancer
|
January 30, 2014
Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
Yanli Jin, Ke Ding, Honglin Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 2, 2012
Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors
Mengzhu Xue, Minghao Xu, Weiqiang Lu, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Genes & Diseases
|
March 26, 2026
<i>SF3B1</i> <sup>K700E</sup>-driven transcriptional alterations in hematopoietic progenitors underlie blood cancer pathophysiology
Mengzhu Xue, Jianhong An, Erqiang Hu, et al.
Kidney & Blood Pressure Research
|
February 18, 2024
Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury
Shanshan Zou, Jianing Chen, Peihui Zhou, et al.
Journal of Chemical Information and Modeling
|
August 5, 2010
Knowledge-based scoring functions in drug design. 1. Developing a target-specific method for kinase-ligand interactions
Mengzhu Xue, Mingyue Zheng, Bing Xiong, et al.
Scientific Reports
|
June 24, 2014
3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network
Li Li, Duolin Wang, Mengzhu Xue, et al.
BMC Bioinformatics
|
January 27, 2010
BSSF: a fingerprint based ultrafast binding site similarity search and function analysis server
Bing Xiong, Jie Wu, David L Burk, et al.
Molecular Cancer
|
October 23, 2021
Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
Yanli Jin, Ke Ding, Honglin Li, et al.
Nucleic Acids Research
|
March 2, 2016
Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition
Hongyuan Chang, Yuwei Liu, Mengzhu Xue, et al.
Current Pharmaceutical Design
|
May 11, 2012
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives
Mengzhu Xue, Xianwen Cao, Ye Zhong, et al.
Molecular Cancer
|
January 30, 2014
Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
Yanli Jin, Ke Ding, Honglin Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 2, 2012
Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors
Mengzhu Xue, Minghao Xu, Weiqiang Lu, et al.
Page
of 4